Combined modality chemoradiation in elderly oesophageal cancer patients

We present a single institution experience with 5-FU, mitomycin-C based chemoradiation for the primary treatment of elderly patients with oesophageal cancer. Twenty-five patients with a median age of 77 years (range 66–88) with a diagnosis of stage II–III squamous cell or adenocarcinoma of the oesop...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, S E, Minsky, B D, Bains, M, Hummer, A, Kelsen, D, Ilson, D H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359964/
https://www.ncbi.nlm.nih.gov/pubmed/17533399
http://dx.doi.org/10.1038/sj.bjc.6603821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359964/
https://www.ncbi.nlm.nih.gov/pubmed/17533399
http://dx.doi.org/10.1038/sj.bjc.6603821

Ejemplares similares